HF Advisory Group, LLC

Position in SNY — Sanofi

CIK 1963169 Annapolis, MD

Position in SNY

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$1,590,748

-$342,763 QoQ

Shares Held

37,289

-7.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.72%

of 13F equity value

Holder Rank

#208

of 712 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

HF Advisory Group, LLC holds $13,388,647 across 8 Drug Manufacturers - General names. SNY ranks #4 (11.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	23,463	$2,964,315
2	LLY	ELI LILLY & Co	2,246	$2,693,920
3	PFE	Pfizer Inc	102,378	$2,465,262
4	SNY	Sanofi This page	37,289	$1,590,748
5	NVS	Novartis AG	8,551	$1,340,112
6	JNJ	Johnson & Johnson	4,322	$1,097,658
7	AMGN	Amgen Inc	2,318	$839,394
8	GSK	GSK plc	7,578	$397,238

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,590,748	37,289	-7.1%	Shares	Sole	2026-07-09
2026-03-31	$1,933,511	40,131	+21.1%	Shares	Sole	2026-04-21
2025-12-31	$1,606,303	33,147	+7.0%	Shares	Sole	2026-01-23
2025-09-30	$1,461,784	30,970	+14.9%	Shares	Sole	2025-10-06
2025-06-30	$1,301,906	26,949	+1.4%	Shares	Sole	2025-07-10
2025-03-31	$1,473,683	26,572	-13.8%	Shares	Sole	2025-04-10
2024-12-31	$1,486,062	30,812	+7.1%	Shares	Sole	2025-01-15
2024-09-30	$1,657,611	28,763	+5.5%	Shares	Sole	2024-10-30
2024-06-30	$1,323,431	27,276	+13.8%	Shares	Sole	2024-07-18
2024-03-31	$1,165,282	23,977	+17.7%	Shares	Sole	2024-04-22
2023-12-31	$1,012,950	20,369	+62.1%	Shares	Sole	2024-01-31
2023-09-30	$674,040	12,566	+9.1%	Shares	Sole	2023-10-31
2023-06-30	$621,089	11,523	+3.1%	Shares	Sole	2023-07-20
2023-03-31	$608,089	11,174	+12.4%	Shares	Sole	2023-04-19
2022-12-31	$481,345	9,939	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.